Literature DB >> 17201136

FGFR-2 and -3 play an important role in initial stages of oral oncogenesis.

Eleftherios Vairaktaris1, Vassilis Ragos, Christos Yapijakis, Spyridoula Derka, Stavros Vassiliou, Emeka Nkenke, Athanassios Yannopoulos, Sofia Spyridonidou, Antonis Vylliotis, Veronica Papakosta, Sofia Loukeri, Andreas Lazaris, Christina Tesseromatis, Christos Tsigris, Efstratios Patsouris.   

Abstract

BACKGROUND: FGFR-2 and FGFR-3 (fibroblast growth factor receptors) have been shown to play an important role in several processes including carcinogenesis. This study was designed to determine gradual FGFR-2 and FGFR-3 expression in sequential stages of oral carcinogenesis in an experimental animal system of Syrian golden hamsters.
MATERIALS AND METHODS: Tissue sections ranging from normal mucosa to squamous cell carcinoma were studied using monoclonal antibodies against FGFR-2 and FGFR-3 proteins.
RESULTS: A significant elevation was revealed in both FGFR-2 and FGFR-3 expression during the stages of dysplasia and early invasion, while in the later stages of oral carcinogenesis the expression of both FGFR-2 and FGFR-3 decreased although not significantly.
CONCLUSION: Our findings indicate that FGFR-2 and FGFR-3 seem to play an important role in the initial stages of oral cancer progression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17201136

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  9 in total

1.  Fibroblast growth factor receptor mediates fibroblast-dependent growth in EMMPRIN-depleted head and neck cancer tumor cells.

Authors:  Zhiyong Liu; Yolanda E Hartman; Jason M Warram; Joseph A Knowles; Larissa Sweeny; Tong Zhou; Eben L Rosenthal
Journal:  Mol Cancer Res       Date:  2011-06-10       Impact factor: 5.852

2.  Inhibition of fibroblasts reduced head and neck cancer growth by targeting fibroblast growth factor receptor.

Authors:  Larissa Sweeny; Zhiyong Liu; William Lancaster; Justin Hart; Yolanda E Hartman; Eben L Rosenthal
Journal:  Laryngoscope       Date:  2012-03-27       Impact factor: 3.325

Review 3.  Tumor microenvironment - Unknown niche with powerful therapeutic potential.

Authors:  Tomasz Kolenda; Weronika Przybyła; Marta Kapałczyńska; Anna Teresiak; Maria Zajączkowska; Renata Bliźniak; Katarzyna M Lamperska
Journal:  Rep Pract Oncol Radiother       Date:  2018-03-17

4.  Cancer-Associated Fibroblasts Drive Glycolysis in a Targetable Signaling Loop Implicated in Head and Neck Squamous Cell Carcinoma Progression.

Authors:  Dhruv Kumar; Jacob New; Vikalp Vishwakarma; Radhika Joshi; Jonathan Enders; Fangchen Lin; Sumana Dasari; Wade R Gutierrez; George Leef; Sivapriya Ponnurangam; Hemantkumar Chavan; Lydia Ganaden; Mackenzie M Thornton; Hongying Dai; Ossama Tawfik; Jeffrey Straub; Yelizaveta Shnayder; Kiran Kakarala; Terance Ted Tsue; Douglas A Girod; Bennett Van Houten; Shrikant Anant; Partha Krishnamurthy; Sufi Mary Thomas
Journal:  Cancer Res       Date:  2018-05-16       Impact factor: 12.701

Review 5.  The role of fibroblast growth factors in tumor growth.

Authors:  M Korc; R E Friesel
Journal:  Curr Cancer Drug Targets       Date:  2009-08-01       Impact factor: 3.428

Review 6.  The Hamster Model of Sequential Oral Carcinogenesis: An Update.

Authors:  Christos Yapijakis; Stefania Kalogera; Veronica Papakosta; Stavros Vassiliou
Journal:  In Vivo       Date:  2019 Nov-Dec       Impact factor: 2.155

7.  Epithelial expression of keratinocytes growth factor in oral precancer lesions.

Authors:  Sudha Jimson; S Murali; Susan L Zunt; Lawrence I Goldblatt; Mythily Srinivasan
Journal:  Dent Res J (Isfahan)       Date:  2016 May-Jun

8.  In silico regulatory analysis for exploring human disease progression.

Authors:  Dustin T Holloway; Mark Kon; Charles DeLisi
Journal:  Biol Direct       Date:  2008-06-18       Impact factor: 4.540

9.  Genomic analysis of head and neck cancer cases from two high incidence regions.

Authors:  Sandra Perdomo; Devasena Anantharaman; Matthieu Foll; Behnoush Abedi-Ardekani; Geoffroy Durand; Luciana Albina Reis Rosa; Reetta Holmila; Florence Le Calvez-Kelm; Eloiza H Tajara; Victor Wünsch-Filho; José Eduardo Levi; Marta Vilensky; Jerry Polesel; Ivana Holcatova; Lorenzo Simonato; Cristina Canova; Pagona Lagiou; James D McKay; Paul Brennan
Journal:  PLoS One       Date:  2018-01-29       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.